In this episode Sacha and Matthew talk about the fascinating psychedelic brews from ancient history. They question if our account of Christian history is correct, and even suggest that psychedelics are in part responsible for the very concept of communing with God. Did Moses really see a burning bush or was he just tripping? Tune in and find out!
Despite an overarching shared thesis, the four psychedelics ETFs differ in philosophy, strategy, execution, and size. This leads them to having different sized stakes companies, and their long-term success will vary.
Understanding and learning Magic Mushrooms: Transformative and Healing Experiences
Biology and experience are tough to separate, but some researchers are exploring the possibility of non-hallucinogenic psychedelics as a mental health treatment. This begs the question: what do we lose, and what do we gain when we take the trip out of the psychedelic experience?
Psychedelic decriminalization has long been the goal of many activists, but it is a long way from true legalization. What’s the difference?
In this episode, Swati Sharma sits down with Jennifer Montjoy, Founder of Transpersonal Research Institute of Psychotherapeutic Psychedelics also known as TRIPP.
The DEA backs off announces they are withdrawing a proposed rule to ban the psychedelic drugs DOI and DOC, at least for now
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.
